MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 8, 2006; DOI: 10.1124/mol.106.026054


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.026054v1
70/6/2004    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cieslik, K. A.
Right arrow Articles by Wu, K. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cieslik, K. A.
Right arrow Articles by Wu, K. K.


Received for publication April 28, 2006.
Revised September 6, 2006.
Accepted for publication September 7, 2006.

ESSENTIAL ROLE OF C-Rel IN NITRIC OXIDE SYNTHASE-2 TRANSCRIPTIONAL ACTIVATION: TIME-DEPENDENT CONTROL BY SALICYLATE

Katarzyna A. Cieslik 1, Wu-Guo Deng 1, Kenneth K. Wu 1*

1 UT Health Science Center, Medical School

* Address correspondence to: E-mail: kenneth.k.wu{at}uth.tmc.edu

Abstract

To determine the role of C-Rel in nitric oxide synthase-2 (NOS-2) transcriptional activation, we evaluated the effect of lipopolysaccharide and interferon-{gamma} (LPS/IFN{gamma}) on C-Rel DNA binding in RAW 264.7. LPS/IFN{gamma}-stimulated C-Rel binding peaked at 4-8 h and declined at 24 h. Transfection of cells with a C-Rel small interfering RNA abrogated C-Rel binding at all time points. LPS/IFN{gamma} produced superoxide at 4 h which subsided at 8 h. C-Rel binding and NOS-2 expression were abrogated by superoxide dismutase or apocynin at 4 h, suggesting a key role that superoxide plays in mediating C-Rel binding and NOS-2 transactivation only at 4 h. We have previously reported that salicylate at 10-5 M inhibited LPS/IFN{gamma}-induced C/EBP{beta} binding at 4 h but not at 8 h or 24 h. A single dose of salicylate did not inhibit C-Rel binding at any time point. Addition of a second dose of salicylate 4 h prior to an indicated end point suppressed C-Rel but not C/EBP{beta} or IRF-1 binding at 8 h and 24 h. A single dose of salicylate added with LPS/IFN{gamma} inhibited NOS-2 expression only at 4 h. However, salicylate supplement inhibited NOS-2 promoter activities, mRNA and protein levels throughout 24 h. Signal profiling with a panel of inhibitors revealed time-dependent switch of signaling pathways. These results demonstrate temporal regulation of transactivator binding by LPS/IFN{gamma} via evolving signaling pathways. We propose that salicylate inhibits C/EBP{beta} binding at 4 h and C-Rel binding at 8 h and 24 h by targeting related kinases.


Key words: Prostanoid, Nitric oxide, Nitric oxide synthases, P38 MAP Kinase, NFkappaB, Cyclooxygenases, RNA/siRNA


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Z. T. Kelleher, A. Matsumoto, J. S. Stamler, and H. E. Marshall
NOS2 Regulation of NF-{kappa}B by S-Nitrosylation of p65
J. Biol. Chem., October 19, 2007; 282(42): 30667 - 30672.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W.-G. Deng, A. J. Montero, and K. K. Wu
Interferon-{gamma} Suppresses Cyclooxygenase-2 Promoter Activity by Inhibiting C-Jun and C/EBP{beta} Binding
Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1752 - 1759.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Brunelli, K. A. Cieslik, J. L. Alcorn, M. Vatta, and A. Baldini
Peroxisome Proliferator-Activated Receptor-{delta} Upregulates 14-3-3{epsilon} in Human Endothelial Cells via CCAAT/Enhancer Binding Protein-{beta}
Circ. Res., March 16, 2007; 100(5): e59 - e71.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics